- 9.4.2024
- News
VARIETY: ‘In Waves and War’ Review: Moving Doc About Afghanistan Vets Treating PTSD With Hallucinogens Is an Odyssey of the Mind
With animated sequences and intimate profiles, 'Athlete A' directors Jon Shenk and Bonni Cohen’s latest is another heartfelt look at a pressing social issue.
- 8.28.2024
- Blog
Navigating Complexity: Reflections on the FDA's MDMA-Assisted Therapy Decision and the Future of Psychedelic Medicine
The FDA’s recent decision to decline approval for MDMA-assisted therapy for PTSD, while disappointing, is not the end of the road. The agency’s request for further research serves as a reminder of the hurdles we still face in advancing psychedelic medicine through regulatory channels.
- 8.14.2024
- News
Microdose: FDA Rejected MDMA-Assisted PTSD Therapy: Psychedelic Industry Responds
Psychedelic industry leaders respond to the FDA's rejection of MDMA-assisted therapy for PTSD, emphasizing the ongoing fight for innovative mental health treatments and the need for new regulatory frameworks.
- 8.10.2024
- News
VETS Stands Firm: Our Response to the FDA's Decision on MDMA-Assisted Therapy
Today, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics in response to their application for approval of MDMA-assisted therapy.
- 8.8.2024
- News
The New York Times: Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy
More than a half century after federal regulators banned most psychedelic compounds, the Food and Drug Administration is nearing a decision on a novel treatment for post-traumatic stress disorder that pairs talk therapy with MDMA.